As of 2026-09-27, the Relative Valuation of Celldex Therapeutics Inc (CLDX) is (82.42) USD. This relative valuation is based on P/E multiples. With the latest stock price at 31.10 USD, the upside of Celldex Therapeutics Inc based on Relative Valuation is -365.0%.
The range of the Relative Valuation is (73.14) - (98.03) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.1x - 25.6x | 22.4x |
| Forward P/E multiples | 15.7x - 25.7x | 20.7x |
| Fair Price | (73.14) - (98.03) | (82.42) |
| Upside | -335.2% - -415.2% | -365.0% |
| Date | P/E |
| 2026-09-25 | -8.12 |
| 2026-09-24 | -8.22 |
| 2026-09-23 | -8.13 |
| 2026-09-22 | -8.75 |
| 2026-09-21 | -9.90 |
| 2026-09-18 | -9.99 |
| 2026-09-17 | -10.18 |
| 2026-09-16 | -10.11 |
| 2026-09-15 | -10.06 |
| 2026-09-14 | -10.23 |
| 2026-09-11 | -9.64 |
| 2026-09-10 | -9.95 |
| 2026-09-09 | -10.13 |
| 2026-09-08 | -10.22 |
| 2026-09-04 | -10.36 |
| 2026-09-03 | -10.28 |
| 2026-09-02 | -10.31 |
| 2026-09-01 | -10.25 |
| 2026-08-31 | -10.35 |
| 2026-08-28 | -10.22 |
| 2026-08-27 | -10.57 |
| 2026-08-26 | -10.60 |
| 2026-08-25 | -10.76 |
| 2026-08-24 | -10.60 |
| 2026-08-21 | -10.55 |
| 2026-08-20 | -10.43 |
| 2026-08-19 | -10.89 |
| 2026-08-18 | -10.91 |
| 2026-08-17 | -10.95 |
| 2026-08-14 | -10.96 |
| 2026-08-13 | -11.13 |
| 2026-08-12 | -11.72 |
| 2026-08-11 | -11.58 |
| 2026-08-10 | -11.22 |
| 2026-08-07 | -10.89 |
| 2026-08-06 | -10.85 |
| 2026-08-05 | -10.72 |
| 2026-08-04 | -10.20 |
| 2026-08-03 | -9.84 |
| 2026-07-31 | -9.94 |
| 2026-07-30 | -10.05 |
| 2026-07-29 | -9.80 |
| 2026-07-28 | -9.29 |
| 2026-07-27 | -9.31 |
| 2026-07-24 | -9.21 |
| 2026-07-23 | -9.25 |
| 2026-07-22 | -9.08 |
| 2026-07-21 | -9.31 |
| 2026-07-20 | -9.25 |
| 2026-07-17 | -9.23 |